Literature DB >> 27398809

Central venous catheter (CVC) removal for patients of all ages with candidaemia.

Susanne Janum1, Arash Afshari.   

Abstract

BACKGROUND: Candida bloodstream infections most often affect those already suffering serious, potentially life-threatening conditions and often cause significant morbidity and mortality. Most affected persons have a central venous catheter (CVC) in place. The best CVC management in these cases has been widely debated in recent years, while the incidence of candidaemia has markedly increased.
OBJECTIVES: The main purpose of this review is to examine the impact of removing versus retaining a CVC on mortality in adults and children with candidaemia who have a CVC in place. SEARCH
METHODS: We searched the following databases from inception to 3 December 2015: Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (Ovid SP), EMBASE (Ovid SP), the Commonwealth Agricultural Bureau (CAB), Web of Science and the Cumulative Index to Nursing and Allied Health Literature (CINAHL). We searched for missed, unreported and ongoing trials in trial registries and in reference lists of excluded articles. SELECTION CRITERIA: We searched for randomized controlled trials (RCTs) and quasi-RCTs involving adults and children with candidaemia and in which participants were randomized for removal of a CVC (the intervention under study), irrespective of publication status, date of publication, blinding status, outcomes published or language.However, two major factors make the conduct of RCTs in this population a difficult task: the large sample size required to document the impact of catheter removal in terms of overall mortality; and lack of economic interest from the industry in conducting such a trial. DATA COLLECTION AND ANALYSIS: Our primary outcome measure was mortality. Several secondary outcome measures such as required time for clearance of blood cultures for Candida species, frequency of persistent candidaemia, complications, duration of mechanical ventilation and length of stay in the intensive care unit (ICU) and in the hospital were planned, as were various subgroup and sensitivity analyses, according to our protocol. We assessed papers and abstracts for eligibility and resolved disagreements by discussion. However, we were not able to include any RCTs or quasi-RCTS in this review and, as a result, have carried out no meta-analyses. However, we have chosen to provide a brief overview of excluded observational studies. MAIN
RESULTS: We found no RCT and thus no available data for evaluation of the primary outcome (mortality) nor secondary outcomes or adverse effects. Therefore, we conducted no statistical analysis.A total of 73 observational studies reported on various clinically relevant outcomes following catheter removal or catheter retention. Most of these excluded, observational studies reported a beneficial effect of catheter removal in patients with candidaemia. None of the observational studies reported results in favour of retaining a catheter. However, the observational studies were very heterogeneous with regards to population, pathogens and interventions. Furthermore, they suffered from confounding by indication and an overall high risk of bias. As a consequence, we are not able to provide recommendations or to draw firm conclusions because of the difficulties involved in interpreting the results of these observational studies (very low quality of evidence, GRADE - Grades of Recommendation, Assessment, Development and Evaluation Working Group). AUTHORS'
CONCLUSIONS: Despite indications from observational studies in favour of early catheter removal, we found no eligible RCTs or quasi-RCTs to support these practices and therefore could draw no firm conclusions. At this stage, RCTs have provided no evidence to support the benefit of early or late catheter removal for survival or other important outcomes among patients with candidaemia; no evidence with regards to assessment of harm or benefit with prompt central venous catheter removal and subsequent re-insertion of new catheters to continue treatment; and no evidence on optimal timing of insertion of a new central venous catheter.

Entities:  

Mesh:

Year:  2016        PMID: 27398809      PMCID: PMC6457908          DOI: 10.1002/14651858.CD011195.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  110 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Removal of central venous catheters from patients with candidemia.

Authors:  Luca Lazzarini; Roberto Luzzati
Journal:  Clin Infect Dis       Date:  2002-10-15       Impact factor: 9.079

Review 3.  The changing face of fungal infections in health care settings.

Authors:  Scott K Fridkin
Journal:  Clin Infect Dis       Date:  2005-10-13       Impact factor: 9.079

4.  Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.

Authors:  M Puig-Asensio; B Padilla; J Garnacho-Montero; O Zaragoza; J M Aguado; R Zaragoza; M Montejo; P Muñoz; I Ruiz-Camps; M Cuenca-Estrella; B Almirante
Journal:  Clin Microbiol Infect       Date:  2013-10-11       Impact factor: 8.067

5.  Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers.

Authors:  Arnaldo L Colombo; Marcio Nucci; Benjamin J Park; Simone A Nouér; Beth Arthington-Skaggs; Daniel A da Matta; David Warnock; Juliette Morgan
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

6.  Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004.

Authors:  Jaffar A Al-Tawfiq
Journal:  Int J Infect Dis       Date:  2006-07-21       Impact factor: 3.623

7.  Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003.

Authors:  Benito Almirante; Dolors Rodríguez; Manuel Cuenca-Estrella; Manel Almela; Ferran Sanchez; Josefina Ayats; Carles Alonso-Tarres; Juan L Rodriguez-Tudela; Albert Pahissa
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

8.  Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research.

Authors:  M G Petri; J König; H P Moecke; H J Gramm; H Barkow; P Kujath; R Dennhart; H Schäfer; N Meyer; P Kalmar; P Thülig; J Müller; H Lode
Journal:  Intensive Care Med       Date:  1997-03       Impact factor: 17.440

9.  Candidemia in children with central venous catheters: role of catheter removal and amphotericin B therapy.

Authors:  V M Dato; A S Dajani
Journal:  Pediatr Infect Dis J       Date:  1990-05       Impact factor: 2.129

10.  Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses.

Authors:  Jesper Brok; Kristian Thorlund; Christian Gluud; Jørn Wetterslev
Journal:  J Clin Epidemiol       Date:  2008-04-14       Impact factor: 6.437

View more
  14 in total

1.  Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia.

Authors:  Lauro Damonti; Véronique Erard; Jorge Garbino; Jacques Schrenzel; Stefan Zimmerli; Konrad Mühlethaler; Alexander Imhof; Reinhard Zbinden; Jan Fehr; Katia Boggian; Thomas Bruderer; Ursula Flückiger; Reno Frei; Christina Orasch; Anna Conen; Nina Khanna; Thomas Bregenzer; Jacques Bille; Frédéric Lamoth; Oscar Marchetti; Pierre-Yves Bochud
Journal:  Intensive Care Med       Date:  2017-03-07       Impact factor: 17.440

2.  Mortality-associated factors of candidemia: a multi-center prospective cohort in Turkey.

Authors:  Murat Kutlu; Selda Sayın-Kutlu; Sema Alp-Çavuş; Şerife Barçın Öztürk; Meltem Taşbakan; Betil Özhak; Onur Kaya; Oya Eren Kutsoylu; Şebnem Şenol-Akar; Özge Turhan; Gülşen Mermut; Bülent Ertuğrul; Hüsnü Pullukcu; Çiğdem Banu Çetin; Vildan Avkan-Oğuz; Nur Yapar; Dilek Yeşim-Metin; Çağrı Ergin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-01-27       Impact factor: 3.267

3.  A longitudinal study of Candida bloodstream infections in a Japanese university hospital: species distribution, drug susceptibility, clinical features, and mortality predictors.

Authors:  Hitoshi Tsukamoto; Takashi Higashi; Takaaki Kodawara; Kyohei Watanabe; Yukio Hida; Hiromichi Iwasaki; Nobuyuki Goto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-09-26       Impact factor: 5.103

4.  Machine-learning based prediction and analysis of prognostic risk factors in patients with candidemia and bacteraemia: a 5-year analysis.

Authors:  Yali Gao; Mingsui Tang; Yaling Li; Xueli Niu; Jingyi Li; Chang Fu; Zihan Wang; Jiayi Liu; Bing Song; Hongduo Chen; Xinghua Gao; Xiuhao Guan
Journal:  PeerJ       Date:  2022-06-15       Impact factor: 3.061

5.  Impact of Infectious Disease Consultation in Patients With Candidemia: A Retrospective Study, Systematic Literature Review, and Meta-analysis.

Authors:  Takaaki Kobayashi; Alexandre R Marra; Marin L Schweizer; Patrick Ten Eyck; Chaorong Wu; Mohammed Alzunitan; Jorge L Salinas; Marc Siegel; Dimitrios Farmakiotis; Paul G Auwaerter; Heather S Healy; Daniel J Diekema
Journal:  Open Forum Infect Dis       Date:  2020-08-03       Impact factor: 3.835

Review 6.  Central venous catheter (CVC) removal for patients of all ages with candidaemia.

Authors:  Susanne Janum; Arash Afshari
Journal:  Cochrane Database Syst Rev       Date:  2016-07-11

7.  Increasing morbidity and mortality of candidemia over one decade in a Swiss university hospital.

Authors:  Julien Battistolo; Emmanouil Glampedakis; Lauro Damonti; Julien Poissy; Bruno Grandbastien; Laetitia Kalbermatter; Jean-Luc Pagani; Philippe Eggimann; Pierre-Yves Bochud; Thierry Calandra; Oscar Marchetti; Frederic Lamoth
Journal:  Mycoses       Date:  2021-10-19       Impact factor: 4.931

8.  Impact of host- and early treatment-related factors on mortality in ICU patients with candidemia: a bicentric retrospective observational study.

Authors:  Shingo Ohki; Nobuaki Shime; Tadashi Kosaka; Naohisa Fujita
Journal:  J Intensive Care       Date:  2020-04-26

9.  Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study.

Authors:  Carlos Mejia-Chew; Jane A O'Halloran; Margaret A Olsen; Dustin Stwalley; Ryan Kronen; Charlotte Lin; Ana S Salazar; Lindsey Larson; Kevin Hsueh; William G Powderly; Andrej Spec
Journal:  Lancet Infect Dis       Date:  2019-09-24       Impact factor: 25.071

10.  Novel and potent antimicrobial effects of caspofungin on drug-resistant Candida and bacteria.

Authors:  Makoto Sumiyoshi; Taiga Miyazaki; Juliann Nzembi Makau; Satoshi Mizuta; Yoshimasa Tanaka; Takeshi Ishikawa; Koichi Makimura; Tatsuro Hirayama; Takahiro Takazono; Tomomi Saijo; Hiroyuki Yamaguchi; Shintaro Shimamura; Kazuko Yamamoto; Yoshifumi Imamura; Noriho Sakamoto; Yasushi Obase; Koichi Izumikawa; Katsunori Yanagihara; Shigeru Kohno; Hiroshi Mukae
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.